The study advances understanding of risk for colon and rectal cancers and points to targets for developing new treatments.

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.

The researchers anticipate that their findings will inform personalized colorectal polyp surveillance, guide therapeutic prevention strategies, and ultimately reduce the burden of colorectal cancer nationwide.

The findings from the current study suggest that magnesium also increases the gut synthesis of vitamin D, which does not go to the blood and takes effect locally.

SPORE grants are highly sought after because they show that a cancer center demonstrates scientific excellence, promotes collaboration, maintains robust research programs and merits substantial funding.

The models allowed patients to easily distinguish the ascending colon from the sigmoid colon, along with other parts of the digestive system.

The awards initiative identifies and recognizes contributions across the field of cancer by rising stars and emerging leaders under the age of 40.